在猫中合理使用胃保护剂:基于证据的方法
1DVM, PhD, DACVIM-SAIM, SA nutrition* Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA.
Journal of feline medicine and surgery
|August 6, 2024
概括
本综述指导兽医在为患有酸性疾病的猫选择合适的胃保护剂. 它强调了解疾病过程,以优化治疗,避免滥用这些常见的兽医药物.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与酸相关的疾病,如食道炎和胃肠,在猫中很罕见,但严重.
- 胃保护剂在兽医中经常被滥用,原因是猫特异性疗效数据有限.
- 当前的治疗方案往往从犬类和人类研究中推断出酸性抑制目标.
研究的目的:
- 根据特定的疾病过程,为选择猫的胃保护剂提供一个逻辑框架.
- 为兽医提供有效启动和终止胃保护疗法的指导.
- 为了解决猫科动物医学中胃保护剂的滥用问题.
主要方法:
- 文献综述综合了有关猫类酸相关疾病的当前证据.
- 纳入兽医内科专家的共识意见.
- 从犬类和人类研究中抽出数据,在缺乏猫类特异性证据的情况下.
主要成果:
- 确定了选择适合猫的胃保护剂的关键考虑因素.
- 强调需要针对食道炎和胃肠道的疾病特异性治疗策略.
- 强调了基于证据的决策在猫的胃保护的重要性.
结论:
- 对猫的胃保护剂选择有理性的方法对于有效管理与酸有关的疾病至关重要.
- 兽医必须仔细考虑潜在的疾病,以优化治疗结果.
- 需要进行进一步的研究,以制定用于胃保护药物的猫特异性指南.
相关概念视频
Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
423
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
423
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
380
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
380
Gastroesophageal Reflux Disease II: Clinical Features and Management
64
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
64
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
363
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
363
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
412
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
412


